ACCO Brands (ACCO) Q1 2026 earnings review
Headline Reversal Masks Underlying Organic Weakness
ACCO Brands reported an 8.3% jump in Q1 net sales and a massive swing to $19.4M in GAAP net income, but these headline figures are highly distorted. The revenue growth was entirely driven by favorable FX (+6.0%) and the EPOS acquisition (+4.8%), while organic comparable sales actually declined 2.5%. The net income figure was artificially inflated by a non-cash $37.6M 'bargain purchase gain' from the EPOS acquisition, without which the company posted a $10.4M operating loss due to restructuring and litigation costs. Despite the noise, there are real operational improvements: the organic sales decline is decelerating, and the multi-year cost reduction program successfully expanded adjusted operating income by 70% to $11.7M.
🐂 Bull Case
Despite ongoing organic volume declines, Adjusted Operating Income jumped to $11.7M from $6.9M in the prior year. The $100 million multi-year cost savings program is working, dropping SG&A to 28.8% of sales.
While comparable sales were down 2.5%, this marks a significant acceleration in trend compared to the steep ~10% organic declines witnessed throughout the middle of 2025.
🐻 Bear Case
The reported positive net income is entirely an accounting artifact (a $37.6M EPOS bargain purchase gain). Excluding this, the company operated at a $10.4M loss due to elevated restructuring and a new $4.0M litigation settlement.
Comparable sales remain negative across both the Americas (-2.3%) and International (-2.8%) segments, pointing to persistent secular weakness in traditional office categories that technology pivots haven't fully offset.
⚖️ Verdict: ⚪
Neutral. The optical turnaround in revenue and earnings is heavily reliant on M&A accounting and FX tailwinds. However, management's aggressive cost-cutting is yielding real cash benefits, and the rate of organic volume deterioration is noticeably slowing down.
Key Themes
Massive Disconnect Between GAAP and Adjusted Profits
Investors should scrutinize the bottom line carefully. GAAP Net Income was $19.4M, but Operating Cash Flow was just $3.5M. The gap is primarily explained by a $37.6M 'bargain purchase gain' linked to the preliminary purchase price allocation of the EPOS acquisition. Meanwhile, actual operating costs surged, pushing GAAP operating loss to $10.4M (worse than last year's $6.7M loss), dragged down by $10.7M in restructuring and litigation settlement expenses.
Cost Savings Defending the Bottom Line
ACCO's multi-year $100M cost reduction program continues to be the company's strongest operational defense. Despite comparable sales falling $8.0M, SG&A expenses dropped to 28.8% of sales. This cost discipline allowed Adjusted Operating Income to increase by $4.8M YoY. Management reaffirmed they are on track to hit the full $100M run-rate target by year-end 2026.
EPOS Acquisition Pivot
The acquisition of premium audio company EPOS officially closed in January 2026, marking a crucial strategic pivot toward faster-growing technology peripherals. The acquisition contributed 4.8% to Q1 top-line growth and management noted it is 'outperforming expectations.' This category shift is vital as secular declines in core office products continue.
Foreign Exchange Provides Artificial Lift
Currency fluctuations provided a massive tailwind this quarter, adding 6.0% ($19.1M) to total consolidated sales. In the International segment alone, favorable FX boosted sales by 9.8%. As management guides for a 'reduced foreign exchange impact' in Q2, reported revenue growth will naturally decelerate.
Elevated Leverage Profile Remains
ACCO ended Q1 with a consolidated leverage ratio of 4.1x. While this is down from its 4.3x peak in mid-2025, it remains elevated for a business experiencing negative organic growth. The company is relying heavily on reaching its targeted $75M-$85M in full-year free cash flow to drive this ratio down to its 3.7x-3.9x guidance range by year-end.
Other KPIs
Stable. Down slightly from $3.3 million in 25Q1. Q1 is traditionally a low-cash-generation quarter for the business due to working capital build. The company maintained its $75M-$85M target for the full year.
Accelerating profitability. Up 28% from $10.0 million in the prior year despite a 2.3% comparable sales decline. Cost savings completely offset unfavorable product mix and volume weakness.
Guidance
Decelerating sequentially from the +8.3% reported in Q1, primarily because management expects the massive foreign exchange tailwinds to moderate. However, achieving this would represent a massive YoY improvement versus the 9.9% contraction suffered in 25Q2.
Stable. The midpoint of $0.26 is largely in line with the $0.28 achieved in 25Q2, reflecting the expected normalization of seasonality and standard business cadence after the noisy Q1.
Reversing. If achieved, this will break a multi-year streak of revenue contraction (FY25 comparable sales were down 9.3%). The growth is highly dependent on the continued integration of the EPOS acquisition and favorable FX holding up through the year.
Stable. Reaffirmed from prior guidance. Represents roughly flat year-over-year performance compared to the ~$0.86 implicitly achieved in FY25 (based on 2025 quarterly summation), showing that cost savings are neutralizing organic top-line pressure.
Key Questions
EPOS Growth Trajectory
With EPOS contributing nearly 5% to top-line growth in Q1 and generating a massive bargain purchase gain, what is the organic growth profile of the EPOS business itself, and when will it be fully integrated into comparable sales metrics?
Path to Organic Growth
Comparable sales are still declining by roughly 2.5% despite easier year-over-year comparisons. What specific catalysts are required to flip comparable sales positive, or is the strategy entirely focused on managing the secular decline via cost cuts?
Litigation Details
The $4.0 million litigation settlement impacted operating margins this quarter. Can you provide context on the nature of this antitrust/patent settlement and confirm that no further liabilities are expected?